3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide

C19H20N2O4 — CID 110730193

IUPAC3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide
SMILESCOc1cc(OC)cc(C(=O)NCCC2C(=O)Nc3ccccc32)c1
InChIInChI=1S/C19H20N2O4/c1-24-13-9-12(10-14(11-13)25-2)18(22)20-8-7-16-15-5-3-4-6-17(15)21-19(16)23/h3-6,9-11,16H,7-8H2,1-2H3,(H,20,22)(H,21,23)
InChIKeyGSBOVUGEAXZSCY-UHFFFAOYSA-N
MW340.38 g/mol
LogP2.56
Rot. Bonds6

About 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide

3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide (PubChem CID 110730193) has the molecular formula C19H20N2O4 and a molecular weight of 340.38 g/mol. Its IUPAC name is 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide.

Molecular Properties

Compound Name3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide
PubChem CID110730193
Molecular FormulaC19H20N2O4
Molecular Weight340.38 g/mol
Exact Mass340.14
IUPAC Name3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide
SMILESCOc1cc(OC)cc(C(=O)NCCC2C(=O)Nc3ccccc32)c1
InChIInChI=1S/C19H20N2O4/c1-24-13-9-12(10-14(11-13)25-2)18(22)20-8-7-16-15-5-3-4-6-17(15)21-19(16)23/h3-6,9-11,16H,7-8H2,1-2H3,(H,20,22)(H,21,23)
InChIKeyGSBOVUGEAXZSCY-UHFFFAOYSA-N
XLogP2.56
TPSA76.66 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms25
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500340.38
LogP ≤ 52.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-methoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide
CID 110730190
4-chloro-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide
CID 110730209
1-(4-methoxyphenyl)-5-methyl-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]triazole-4-carboxamide
CID 126787614
N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]-2-phenoxyacetamide
CID 110730204
methyl 3-(2-oxo-1,3-dihydroindol-3-yl)propanoate
CID 14903583
1-[2-[(3S)-2-oxo-1,3-dihydroindol-3-yl]ethyl]-3-phenylurea
CID 31771075
N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]cyclohexanecarboxamide
CID 110730173
N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]-2-thiophen-2-ylacetamide
CID 110730198
4-(3,5-dimethylpyrazol-1-yl)-N-[2-[(3R)-5-methoxy-2-oxo-1,3-dihydroindol-3-yl]ethyl]benzamide
CID 98139514
N-[2-(2,5-dioxoimidazolidin-4-yl)ethyl]-3-methoxybenzamide
CID 110722120
3-(3,4-dimethoxyphenyl)-N-[2-[(3R)-2-oxo-1,3-dihydroindol-3-yl]ethyl]-1-phenylpyrazole-4-carboxamide
CID 51514887
N-[2-[(3S)-5-methoxy-2-oxo-1,3-dihydroindol-3-yl]ethyl]-4-methyl-3-morpholin-4-ylbenzamide
CID 92627067

Frequently Asked Questions

What is the IUPAC name of 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide?
The IUPAC name of 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide (CID 110730193) is 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide.
What is the SMILES notation for 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide?
The canonical SMILES for 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide is COc1cc(OC)cc(C(=O)NCCC2C(=O)Nc3ccccc32)c1.
What is the InChIKey of 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide?
The InChIKey is GSBOVUGEAXZSCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20N2O4/c1-24-13-9-12(10-14(11-13)25-2)18(22)20-8-7-16-15-5-3-4-6-17(15)21-19(16)23/h3-6,9-11,16H,7-8H2,1-2H3,(H,20,22)(H,21,23).
What are the key properties of 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide?
3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide has a molecular weight of 340.38 g/mol, XLogP of 2.56, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-dimethoxy-N-[2-(2-oxo-1,3-dihydroindol-3-yl)ethyl]benzamide is sourced from PubChem (CID 110730193), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).